The U.S. National Institutes of Health is launching a national molecular library to accelerate the development of new drugs and nano-scale agents for an emerging “era of personalized medicine.”

The library will act as a repository “for some of the hundreds of thousands of molecules the pharmaceutical industry screens for their use in identifying target agents that could be used to track or treat diseases.”